Repeated intratunical injection of adenovirus expressing transforming growth factor-β1 in a rat induces penile curvature with tunical fibrotic plaque: A useful model for the study of Peyronie's disease

International Journal of Andrology

Volumn 31, Issue 3, 2008, Pages 346-353

  Piao, Shuguang ^a   Ryu, Ji Kan ^a   Shin, Hwa Yean ^a   Zhang, Luwei ^a   Song, Sun U ^a   Han, Jee Young ^a   Park, Seok Hee ^a   Kim, Joon Mee ^a   Kim, In Hoo ^b   Kim, Seong Jin ^c   Suh, Jun Kyu ^a,d  

^a Inha University School of Medicine   (South Korea)

^b National Cancer Center   (South Korea)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Inha University Hospital   (South Korea)

Author keywords

Animal model; Penile curvature; Peyronie's disease; Transforming growth factor beta

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA1;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; HISTOPATHOLOGY; INFLAMMATORY CELL; MALE; NONHUMAN; PENILE FIBROSIS; PENIS ERECTION; PEYRONIE DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TUNICA ALBUGINEA;

ADENOVIRIDAE; ANIMALS; CALCINOSIS; CARTILAGE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ELASTIN; FIBROSIS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; INJECTIONS; MALE; PENILE ERECTION; PENILE INDURATION; PENIS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SWINE; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 43249107213     PISSN: 01056263     EISSN: 13652605     Source Type: Journal    
DOI: 10.1111/j.1365-2605.2007.00780.x     Document Type: Article

References (17)

1. Anafarta, K., Beduk, Y., Uluoglu, O., Aydos, K. Baltaci, S. (1994) The significance of histopathological changes of the normal tunica albuginea in Peyronie's disease. International Urology and Nephrology 26, 71 77.
2. Bivalacqua, T. J., Diner, E. K., Novak, T. E., Vohra, Y., Sikka, S. C., Champion, H. C., Kadowitz, P. J. Hellstrom, W. J. (2000) A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression. Journal of Urology 163, 1992 1998.
3. Bosse, A., Wulf, M., Wiethege, T., Voss, B. Muller, K. M. (1994) Collagens and growth factors in heterotopic ossification. Pathologe 15, 216 225.
4. Davila, H. H., Ferrini, M. G., Rajfer, J. Gonzalez-Cadavid, N. F. (2003) Fibrin as an inducer of fibrosis in the tunica albuginea of the rat a new animal model of Peyronie's disease. BJU International 91, 830 838.
5. Devine, C. J., Jr., Somers, K. D., Jordan, S. G. Schlossberg, S. M. (1997) Proposal: trauma as the cause of the Peyronie's lesion. Journal of Urology 57, 285 290.
6. El-Sakka, A. I., Hassoba, H. M., Pillarisetty, R. J., Dahiya, R. Lue, T. F. (1997a) Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression. Journal of Urology 158, 1391 1394.
7. El-Sakka, A. I., Hassoba, H. M., Chui, R. M., Bhatnagar, R. S., Dahiya, R. Lue, T. F. (1997b) An animal model of Peyronie's-like condition associated with an increase of transforming growth factor beta mRNA and protein expression. Journal of Urology 158, 2284 2290.
8. El-Sakka, A. I., Hassan, M. U., Nunes, L., Bhatnagar, R. S., Yen, T. S. Lue, T. F. (1998) Histological and ultrastructural alterations in an animal model of Peyronie's disease. British Journal of Urology 81, 445 452.
9. Ferrini, M. G., Vernet, D., Magee, T. R., Shahed, A., Qian, A., Rajfer, J. Gonzalez-Cadavid, N. F. (2002) Antifibrotic role of inducible nitric oxide synthase (iNOS). Nitric Oxide 6, 1 12.
10. Hsu, G. L., Brock, G., Martinez-Pinero, L., von Heyden, B. Lue, T. F. (1992) The three dimensional structure of the human tunica albuginea: anatomical and ultrastructural levels. International Journal of Impotence Research 4, 117 129.
11. Jarow, J. P. Lowe, F. C. (1997) Penile trauma. An etiologic factor in Peyronie's disease and erectile dysfunction. Journal of Urology 158, 1388 1390.
12. Lowsley, O. S. Boyce, W. H. (1950) Further experiences with an operation for the cure of Peyronie's disease. Journal of Urology 63, 888 902.
13. Mulhall, J. P., Creech, S. D., Boorjian, S. A., Ghaly, S., Kim, E. D., Moty, A., Davis, R. Hellstrom, W. (2001) Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening. Journal of Urology 171, 2350 2353.
14. Schwarzer, U., Sommer, F., Klotz, T., Braun, M., Reifenrath, B. Engelmann, U. (2001) The prevalence of Peyronie's disease: results of a large survey. BJU International 88, 727 730.
15. Somers, K. D. Dawson, D. M. (1997) Fibrin deposition in Peyronie's disease plaque. Journal of Urology 157, 311 315.
16. Vernet, D., Ferrini, M. G., Valente, E. G., Magee, T. R., Bou-Gharios, G., Rajfer, J. Gonzalez-Cadavid, N. F. (2002) Effect of nitric oxide on fibroblast differentiation into myofibroblasts in cell cultures from the Peyronie's fibrotic plaque and in its rat model in vivo. Nitric Oxide 7, 262 276.
17. Yudkin, J. S. (1977) Peyronie's disease in association with metoprolol. Lancet 2, 1355.